The market for drug discovery technologies is estimated to generate US$ 59 billion in revenue in 2022 and US$ 81.5 billion by the end of 2026. This is because it is predicted that from 2022 to 2026, the global demand for drug discovery technologies will grow at a CAGR of 8.4%. The market for drug discovery technologies in China is anticipated to reach US$ 12 billion by 2026, growing at an impressive CAGR of almost 10% over that time.

The offer in this section includes a variety of opportunities, such as the ability to manufacture goods and provide retail, wholesale, and exhibiting services. The researchers at Fact.MR have used extensive rounds of both necessary and optional research to arrive at various estimations and projections for the market need for drug discovery technologies, both globally and provincially.

Download a Sample Copy of This Report: –https://www.factmr.com/connectus/sample?flag=S&rep_id=7589?PJ 

Market Players: –

  • Arqule
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Albany Molecular Research
  • Celera Corp
  • Charles River Laboratories International
  • Molecular Discovery Ltd.
  • Bio-Rad Laboratories
  • Caliper Life Sciences
  • Evotec Ag
  • Gyros AbIncyte Corp.
  • Novartis AG
  • Affymetrix Inc.
  • Agilent Technologies Inc.

Competitive Landscape :

Companies in the drug discovery technologies market are expected to focus on launching new solutions to enhance drug discovery and drug development.

  • In July 2022, Dotmatics, an R&D scientific software organization, announced the release of its new Chemistry Solution for Small Molecule Drug Discovery. The new solution is a compilation of workflows, R&D applications, and the company’s enterprise scientific platform to provide best practices for small molecule drug discovery and development.

Segments of Drug Discovery Technologies Industry Research

  • By Drug Type :
    • Small Molecule Drugs
    • Biologic Drugs
  • By Technology :
    • High Throughput Screening
    • Genomics
    • Biochips
    • Pharmacogenomics
    • Bioanalytical Instruments
    • Bioinformatics
    • Nanotechnology in Drug Discovery
    • Other Technologies
  • By End User :
    • Pharmaceutical Companies
    • Biopharmaceutical Companies
    • Biotechnology Companies
    • Research Institutes
    • Other End Users

What Do You Get in a Fact.MR Study?

  • Factors affecting the overall development of the global Drug Discovery Technologies Market
  • Factor that might restrain the growth of the global market in the coming years of the forecast period.
  • What is present competitive scenario of the global Drug Discovery Technologies Market and its intricate details concerning potential business prospects of leading market players
  • Pricing strategies of several different market players in the global Drug Discovery Technologies Market

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
  • EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
  • CIS & Russia
  • Japan
  • Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)

How Fact.MR Assists in Making Strategic Moves?

The data provided in the Drug Discovery Technologies Market report offers comprehensive analysis of important industry trends. Industry players can use this data to strategize their potential business moves and gain remarkable revenues in the upcoming period.

The report covers the price trend analysis and value chain analysis along with analysis of diverse offering by market players. The main motive of this report is to assist enterprises to make data-driven decisions and strategize their business moves.